Cost-effectiveness of recombinant tissue-type plasminogen activator for acute ischaemic stroke with unknown time of onset: a Markov modelling analysis from the Chinese and US perspectives

OBJECTIVE: The effectiveness of MRI-guided intravenous recombinant tissue-type plasminogen activator (r-tPA) for acute ischaemic stroke (AIS) with an unknown time of onset has been demonstrated by the WAKE-UP Trial. We aim to evaluate its long-term cost-effectiveness from the perspective of Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Songfeng, Cheng, Yuhong, Tong, Xin, Han, Mingyang, Ji, Linjin, Che, Yuxiong, Hu, Weiwu, Liu, Aihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664282/
https://www.ncbi.nlm.nih.gov/pubmed/36375982
http://dx.doi.org/10.1136/bmjopen-2022-065133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664282/
https://www.ncbi.nlm.nih.gov/pubmed/36375982
http://dx.doi.org/10.1136/bmjopen-2022-065133

Ejemplares similares